Science Explorer Back to mapMap
Discussion
Researcher · Epic Sciences (United States) · United States

Ryan Vance Dittamore

Ryan Vance Dittamore publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics and Cancer Cells and Metastasis.

ORCID 0000-0003-2281-3232 OpenAlex
World rank
#234,285
of 7,710,434 ranked researchers
Rank in United States
#86,413
of 1,627,098
Works
182
Citations
4.2k
Citations per work
23.3
h-index
29
i10-index 38Top 12% in Oncology
Ryan Vance Dittamore

What does Ryan Vance Dittamore research?

Ryan Vance Dittamore's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (23%).

Health Sciences: 125 works · 68.6% of their workMedicine: 125 works · 68.6% of their workOncology: 52 works · 28.6% of their workPulmonary and Respiratory Medicine: 48 works · 26.1% of their workRadiology, Nuclear Medicine and Imaging: 18 works · 10.1% of their workSurgery: 7 works · 3.8% of their workLife Sciences: 42 works · 23.2% of their workBiochemistry, Genetics and Molecular Biology: 42 works · 23.2% of their workCancer Research: 33 works · 18.3% of their workMolecular Biology: 9 works · 4.9% of their workEverything else: 15 works · 8.2% of their workTHEIR WORKRyan VanceDittamore182works
Life Sciences23%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12568.6%
    1. Biochemistry, Genetics and Molecular Biology4223.2%
  3. Everything else158.2%
  1. 1Oncology29% of their works
  2. 2Pulmonary and Respiratory Medicine26% of their works
  3. 3Cancer Research18% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Molecular Biology5% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Ryan Vance Dittamore's research?

The keywords of their largest research topics: Targeted Therapy, Immunotherapy, Clinical Trials, Genomic Profiling, Androgen Receptor, Prostate Cancer, Cancer Genomics and Mutational Signatures.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy973 topics
  2. Immunotherapy882 topics
  3. Clinical Trials842 topics
  4. Genomic Profiling842 topics
  5. Androgen Receptor741 topic
  6. Prostate Cancer741 topic
  7. Cancer Genomics631 topic
  8. Mutational Signatures631 topic
  9. Cancer Stem Cells561 topic
  10. Tumor Metastasis561 topic
  11. Immune Checkpoint Blockade301 topic
  12. PD-1 and PD-L1301 topic
  13. PET Imaging241 topic
  14. Radiopharmaceuticals241 topic
  15. BRCA Mutation141 topic
  16. Bladder Cancer141 topic
  17. PARP Inhibitors141 topic
  18. Urothelial Carcinoma141 topic
  19. ALK Inhibitors101 topic
  20. EGFR Mutations101 topic

Where does Ryan Vance Dittamore work?

Ryan Vance Dittamore's main affiliation in the publication record is Epic Sciences (United States), United States.

How many publications and citations does Ryan Vance Dittamore have?

OpenAlex counts 182 works and 4,247 citations for Ryan Vance Dittamore, an h-index of 29, ranking #234,285 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ryan Vance Dittamore. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.